Skip to main content

Table 1 Activity of KP46 and obatoclax as compared to standard OS chemotherapeutic agents

From: Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition

Cell Line

KP46 (μM)

Cisplatin (μM))

Methotrexate (μM)

Doxorubicin (nM)

Obatoclax (nM)

 

IC50 values (mean ± SD)

MG-63

1.204 ± 0.392

7.055 ± 1.6

>50

111.8 ± 87.6

102.9 ± 19.9

HOS

1.210 ± 0.344

6.732 ± 2.5

>50

77.6 ± 16.2

65.1 ± 12.8

U-2 OS

3.830 ± 1.232

8.169 ± 3.2

>50

162.5 ± 123.7

306.7 ± 171.9

SAOS-2

1.641 ± 0.113

5.277 ± 2.1

>50

100.6 ± 4.1

74.0 ± 6.3

HLF

9.01 ± 0.012

3.919 ± 1.2

>50

>250

154.6 ± 15.0